Pulmonary Fibrosis Secondary to Systemic Sclerosis
2 clinical trials · Condition
◉ Watch Pulmonary Fibrosis Secondary to Systemic Sclerosis
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis (NCT06329401) | Avalyn Pharma Inc. | 2024-04-03 |
| QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis (NCT00581997) | Novartis Pharmaceuticals | 2007-12-01 |
Track Pulmonary Fibrosis Secondary to Systemic Sclerosis automatically
Every clearance here is in the API, with alerts when new ones post.